We are investigating whether the directors of Oak Street Health, Inc. (NYSE: OSH) (“Oak Street”) acted in the best interests of Oak Street shareholders in approving the sale of Oak Street to CVS Health Corporation (“CVS”) for $39.00 per share in cash.
If you remain an Oak Street shareholder and have questions about your legal rights, you may contact our firm to discuss your options at no charge by completing and submitting the form below.
Why is there an investigation?
On February 8, 2023, Oak Street announced that it had agreed to be acquired by CVS for $39.00 per share in cash. The agreement has been approved by the Oak Street board of directors (“Board”).
“Our investigation concerns whether Oak Street’s Board acted in the best interests of Oak Street shareholders in approving the sale,” explained Joshua Fruchter, one of the firm’s name partners. “This includes whether the acquisition price adequately compensates Oak Street shareholders, and whether all material information regarding the transaction has been fully disclosed.”
Notably, according to an analysis of Wall Street price targets for Oak Street in the last 90 days published on Seeking Alpha, there is a high price target of $47.00 per share, which is above the deal price.